CEI
IRWD icon

Clark Estates Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Clark Estates Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-355,000
Closed -$4.09M – 96
2022
Q2 		$4.09M Hold
355,000
– – 0.71% 41
2022
Q1 		$4.47M Hold
355,000
– – 0.7% 44
2021
Q4 		$4.14M Hold
355,000
– – 0.61% 64
2021
Q3 		$4.64M Hold
355,000
– – 0.66% 40
2021
Q2 		$4.57M Buy
+355,000
New +$4.06M 0.6% 51

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clark Estates Inc's IRWD Position: Q3 2022 in Review

Clark Estates Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2022, closing a stake of 355,000 shares — an estimated $4.09M sold.

Clark Estates Inc first reported a position in IRWD in Q2 2021 and held it in 5 quarters. The position peaked at $4.64M in Q3 2021. 245 funds tracked by Wall St. Rank hold IRWD as of Q3 2022.

  • Clark Estates Inc reported no remaining Ironwood Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Clark Estates Inc sold 355,000 Ironwood Pharmaceuticals shares in Q3 2022, an estimated $4.09M.
  • Clark Estates Inc first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Clark Estates Inc's Ironwood Pharmaceuticals position peaked at $4.64M in Q3 2021.
  • 245 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2022.

Based on Clark Estates Inc's 13F filing for Q3 2022, filed 14 Nov 2022.